A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

by Endlicher Esther, Heinemann Volker, Schmiegel Wolff, Kanzler Stephan, Gregor Michael, Hofheinz Ralf, Harder Jan, Büchler Peter, Mihaljevic Andre, Klöppel Günter, Seufferlein Thomas, Geissler Michael
Published 2009-01-01